10/31/2024 3:59 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2024 8:45 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/28/2024 7:35 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/24/2024 7:30 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024 8:35 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/09/2024 8:13 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/06/2024 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
|
10/01/2024 5:00 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form POS AM | |
09/30/2024 3:53 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/24/2024 8:25 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024 5:10 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/09/2024 5:10 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/30/2024 4:00 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/28/2024 6:05 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/26/2024 7:00 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2024 8:00 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2024 8:24 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/09/2024 8:29 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2024 8:11 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/01/2024 7:05 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024 7:20 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
06/27/2024 7:00 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024 7:16 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
06/24/2024 8:20 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2024 3:42 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2024 4:24 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
06/17/2024 4:25 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
06/17/2024 4:22 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024 6:14 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2024 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
05/20/2024 3:16 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form F-1/A | |
05/20/2024 8:02 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024 8:02 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024 9:21 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024 3:01 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
04/12/2024 3:30 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/12/2024 3:30 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B5 | |
04/10/2024 8:00 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2024 7:32 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
04/08/2024 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
[625,000% Gain] – Are You Ready for the Next Altcoin Boom? (Ad) All of our key indicators are flashing the same signal: an altcoin season is fast approaching.
And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen. Register for the FREE Workshop Now & get $10 in Bitcoin |
04/05/2024 8:28 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024 4:10 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form POS AM | |
04/04/2024 3:31 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
04/04/2024 3:37 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form POS AM | |
02/22/2024 7:25 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/13/2024 12:20 PM | Gordon Ariel (Filed by) NeuroSense Therapeutics Ltd. (Subject) NeuroSense Therapeutics (Subject)
| Form SC 13G/A | |
02/13/2024 9:14 AM | Ben-Noon Alon (Filed by) NeuroSense Therapeutics Ltd. (Subject) NeuroSense Therapeutics (Subject)
| Form SC 13G/A | |
02/07/2024 8:38 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/09/2024 7:48 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/09/2024 7:49 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023 4:01 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023 4:03 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
12/21/2023 7:45 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2023 3:30 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
12/14/2023 8:41 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2023 2:00 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
12/05/2023 2:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 424B3 | |
12/05/2023 7:01 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2023 11:15 PM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form EFFECT | |
12/04/2023 5:17 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form POS AM | |
11/28/2023 8:00 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/21/2023 9:36 AM | NeuroSense Therapeutics Ltd. (Filer) NeuroSense Therapeutics (Filer)
| Form POS AM | |